Cartilage Biomarker Response to Acute Mechanical Loading in Women With Knee Osteoarthritis: Comparison by Antiresorptive Treatment Status
A legfontosabb adatok
- Ki végzi
- Sisli Hamidiye Etfal Training and Research Hospital
- Hol
- Istanbul (Törökország)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 105 fő, tervezett
- Kezdés
- 2026. máj. 8.
- Várható befejezés
- 2027. febr. 10.
- A vizsgálat típusa
- Megfigyeléses, 3 csoport
- A regiszteradat frissítve
- 2026. október 20.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for women past menopause, aged 60-80 years, with mild-to-moderate knee osteoarthritis and osteoporosis or osteopenia (thin bones). They walk on a treadmill for 30 minutes and give blood before and after.
- Életkor
- 60-80 years
- Nem
- Women only (postmenopausal)
- A betegség stádiuma
- Knee osteoarthritis confirmed by exam and X-ray, Kellgren-Lawrence grade 2 or 3 in at least one knee. Pain of at least 20 mm on the VAS scale during activity. Osteoporosis or osteopenia confirmed by DEXA bone scan. Must not have sarcopenia (muscle loss) by the STAR protocol. Must be able to walk 30 minutes on a treadmill.
- Korábbi kezelés
- Groups by current bone treatment: denosumab for at least 12 months (last dose 2-4 months before), the same bisphosphonate for at least 12 months, or no antiresorptive treatment (never used, or bisphosphonate stopped at least 5 years ago). No change in antiresorptive therapy in the past 6 months. No previous osteoanabolic therapy. No knee joint injection in the past 12 months.
- Biomarker vagy leletérték
- Knee MRI within the past 3 months and X-rays of both hands within the past 6 months are needed.
A részvétel fő kizáró okai
- Inflammatory arthritis, such as rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis, or an active gout or CPPD attack
- Knee replacement or major knee surgery in the past
- Steroid pills for ≥3 months at ≥5 mg/day of prednisone or equal
- eGFR <30 mL/min, NYHA class III-IV heart failure, or uncontrolled diabetes or high blood pressure
- Nerve disease that greatly limits walking, or cognitive impairment
A regiszter feltételei, szó szerint
Mind a 21 feltétel megnézéseKevesebb
Ki vehet részt
- Postmenopausal women aged 60-80 years
- DEXA-confirmed diagnosis of osteoporosis or osteopenia
- Clinically and radiographically confirmed knee osteoarthritis, with Kellgren-Lawrence grade 2 or 3 in at least one knee
- Knee MRI performed within the previous 3 months
- Bilateral hand radiographs performed within the previous 6 months
- Pain intensity of at least 20 mm on the Visual Analog Scale (VAS) during activity
- Ability to tolerate the standardized acute mechanical loading protocol consisting of 30 minutes of treadmill walking
- Non-sarcopenic status according to the STAR protocol
- Ability to provide written informed consent
Ki nem vehet részt
- Intra-articular knee injection within the previous 12 months
- Change in antiresorptive therapy within the previous 6 months
- Previous osteoanabolic therapy
- Systemic corticosteroid use for ≥3 months at a dose equivalent to ≥5 mg/day of prednisone
- History of total knee arthroplasty or major knee surgery
- New York Heart Association (NYHA) class III-IV heart failure
- Uncontrolled diabetes mellitus or hypertension
- Neurological disease significantly limiting walking
- Cognitive impairment
- Active gout or calcium pyrophosphate deposition (CPPD) attack
- Glomerular filtration rate (eGFR) <30 mL/min
- Inflammatory arthritis, including rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 60 és 80 év között vagy?
Ez a vizsgálat jelenleg itt érhető el: Törökország.
- Şişli Hamidiye Etfal Training and Research HospitalIstanbul, TörökországContact: Alperen TayfurRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
This study evaluates how acute mechanical loading affects cartilage degradation biomarkers in postmenopausal women with mild-to-moderate knee osteoarthritis. Participants will be grouped according to their existing antiresorptive treatment status: denosumab users, bisphosphonate users, and a control group. All participants will undergo a 30-minute treadmill walking session at a comfortable and tolerated speed. Blood samples will be collected immediately before and within 0-2 minutes after walking to measure changes in cartilage degradation biomarkers, including cartilage oligomeric matrix protein (COMP) and matrix metalloproteinase-3 (MMP-3). The study aims to determine whether the biomarker response to acute mechanical loading differs according to antiresorptive treatment status.
A vizsgálat 3 csoportja
- Denosumab Group
Postmenopausal women aged 60-80 years with DEXA-confirmed osteoporosis and clinically and radiographically confirmed knee osteoarthritis who have been regularly receiving denosumab for at least 12 months, with the last dose administered 2-4 months before the study assessment.
- Bisphosphonate Group
Postmenopausal women aged 60-80 years with DEXA-confirmed osteoporosis and clinically and radiographically confirmed knee osteoarthritis who have been regularly receiving the same bisphosphonate for at least 12 months.
- Control Group
Postmenopausal women aged 60-80 years with DEXA-confirmed osteopenia and clinically and radiographically confirmed knee osteoarthritis who are not currently receiving antiresorptive treatment and have either never used antiresorptive treatment or discontinued bisphosphonate treatment at least 5 years ago.
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Response of Cartilage Degradation Biomarkers to Acute Mechanical Loading and the Effect of Antiresorptive Therapy in Postmenopausal Women With Mild-to-Moderate Knee Osteoarthritis
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Kérdések a feltételekről
- Forrás: NCT07881861: ki vehet részt
- A regiszteradat frissítve
- 2026. október 20.